INPLASY202440097

Identifying Subgroups Deriving the Most Benefit from PD-1 Checkpoint Inhibition plus Chemotherapy in Advanced Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

Keywords: Breast cancer; immunotherapy; immune checkpoint inhibitors (ICI); pembrolizumab; atezolizumab; progression-free survival.

Download PDF - 202440097

Review Status: completed but not published